HomeInsightsResults

Bajaj Healthcare Ltd Quarterly Result

Bajaj Healthcare Ltd Quarterly Result

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

6.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Bajaj Healthcare Ltd

NSE: BAJAJHCARE

Net Profit

₹ 9.46

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Bajaj Healthcare Ltd for the Sep '24 is ₹ 136.82 crore as compare to the Jun '24 revenue of ₹ 133.1 crore. This represent the growth of 2.7948918%.
  • The ebitda of Bajaj Healthcare Ltd for the Sep '24 is ₹ 28.25 crore as compare to the Jun '24 ebitda of ₹ 24.46 crore. This represent the growth of 15.49469%.
  • The net profit of Bajaj Healthcare Ltd for the Sep '24 is ₹ 9.46 crore as compare to the Jun '24 net profit of ₹ 7.13 crore. This represent the growth of 32.67882%.

Results Analysis

Market Price of Bajaj Healthcare Ltd

1M

1Y

3Y

5Y

Monitoring Bajaj Healthcare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024391.45
21 Nov 2024385.15
19 Nov 2024392.15
18 Nov 2024381.8
14 Nov 2024390.75
13 Nov 2024362.65
12 Nov 2024384.5
11 Nov 2024388.35
08 Nov 2024395.25
07 Nov 2024395.55

Historical Revenue of Bajaj Healthcare Ltd

No data available

* All values are in crore

Historical EBITDA of Bajaj Healthcare Ltd

No data available

* All values are in crore

Historical Net Profit of Bajaj Healthcare Ltd

No data available

* All values are in crore

Bajaj Healthcare Ltd News Hub

News

Bajaj Healthcare reports turnaround Q2 performance

Revenue from operations jumped 31.5% YoY to Rs 133.08 crore in Q2 FY25. Profit before tax ...

Read more

16 Nov 202412:28

News

Bajaj Healthcare announces board meeting date

Bajaj Healthcare will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

11 Nov 202417:30

News

Bajaj Healthcare enters into API development and supply agreement with European company

Bajaj Healthcare has entered into a development and supply agreement for an Active Pharmac...

Read more

23 Sep 202413:06

News

Bajaj Healthcare gains on inking pact with European entity

After the development, the API will be initially supplied in small quantities and will be ...

Read more

23 Sep 202412:47

News

Board of Bajaj Healthcare approves preferential allotment of shares and warrants

The Board of Bajaj Healthcare at its meeting held on 19 September 2024 has approved the al...

Read more

19 Sep 202413:53

News

Bajaj Healthcare schedules AGM

Bajaj Healthcare announced that the Annual General Meeting (AGM) of the company will be he...

Read more

18 Sep 202416:44

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Bajaj Healthcare Ltd Quarterly Result

What is the EPS of Bajaj Healthcare Ltd stock?

The Earnings Per Share (EPS) of Bajaj Healthcare Ltd is 12.4. An EPS is the amount of net income attributed to each share of a common stock.

How is Bajaj Healthcare Ltd EPS calculated?

The EPS of Bajaj Healthcare Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Bajaj Healthcare Ltd report its EPS?

Bajaj Healthcare Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Bajaj Healthcare Ltd EPS?

Factors that influence the EPS of Bajaj Healthcare Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Bajaj Healthcare Ltd EPS growth indicate future performance?

Yes, consistent growth in Bajaj Healthcare Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*